Resistine (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Resistine" in Dutch language version.

refsWebsite

Global rank Dutch rank

22nih.gov

4^th place

12^th place

21doi.org

2^nd place

8^th place

7archive.org

6^th place

25^th place

2worldcat.org

5^th place

28^th place

archive.org (Global: 6^th place; Dutch: 25^th place)

Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (January 2001). The hormone resistin links obesity to diabetes. Nature 409 (6818): 307–12. PMID 11201732. DOI: 10.1038/35053000.
Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N (October 2002). Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 (10): 2951–8. PMID 12351432. DOI: 10.2337/diabetes.51.10.2951.
McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S (January 2002). Resistin, central obesity, and type 2 diabetes. Lancet 359 (9300): 46–7. PMID 11809189. DOI: 10.1016/S0140-6736(02)07281-1.
Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale Jr FV, Shelton DL, Hébert CC (August 2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19 (15): 4046–55. PMID 10921885. PMC 306596. DOI: 10.1093/emboj/19.15.4046.
Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (December 2006). Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant. Proc. 38 (10): 3434–6. PMID 17175295. DOI: 10.1016/j.transproceed.2006.10.140.
Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (August 2003). Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (6): 736–40. PMID 12874180. DOI: 10.1161/01.CIR.0000084503.91330.49.
Wellen KE, Hotamisligil GS (May 2005). Inflammation, stress, and diabetes. J. Clin. Invest. 115 (5): 1111–9. PMID 15864338. PMC 1087185. DOI: 10.1172/JCI25102.

doi.org (Global: 2^nd place; Dutch: 8^th place)

Wang H, Chu WS, Hemphill C, Elbein SC (June 2002). Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87 (6): 2520–4. PMID 12050208. DOI: 10.1210/jcem.87.6.8528.
Lazar MA (October 2007). Resistin- and Obesity-associated metabolic diseases. Horm. Metab. Res. 39 (10): 710–6. PMID 17952831. DOI: 10.1055/s-2007-985897.
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (January 2001). The hormone resistin links obesity to diabetes. Nature 409 (6818): 307–12. PMID 11201732. DOI: 10.1038/35053000.
Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, Considine RV (November 2003). Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88 (11): 5452–5. PMID 14602788. DOI: 10.1210/jc.2002-021808.
Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N (October 2002). Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 (10): 2951–8. PMID 12351432. DOI: 10.2337/diabetes.51.10.2951.
Levy JR, Davenport B, Clore JN, Stevens W (March 2002). Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. Am. J. Physiol. Endocrinol. Metab. 282 (3): E626–33. PMID 11832366. DOI: 10.1152/ajpendo.00346.2001.
McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S (January 2002). Resistin, central obesity, and type 2 diabetes. Lancet 359 (9300): 46–7. PMID 11809189. DOI: 10.1016/S0140-6736(02)07281-1.
Adeghate E (October 2004). An update on the biology and physiology of resistin. Cell. Mol. Life Sci. 61 (19–20): 2485–96. PMID 15526156. DOI: 10.1007/s00018-004-4083-2.
Stumvoll M, Häring H (November 2002). Resistin and adiponectin--of mice and men. Obes. Res. 10 (11): 1197–9. PMID 12429885. DOI: 10.1038/oby.2002.162.
Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C (June 2004). Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12 (6): 962–71. PMID 15229336. DOI: 10.1038/oby.2004.118.
Vidal-Puig, A., O'Rahilly, S. (2001). Resistin: a new link between obesity and insulin resistance?. Clinical Endocrinology 55 (4): 437–438. ISSN: 0300-0664. PMID 11678824. DOI: 10.1046/j.1365-2265.2001.01377.x.
Lazar, M. A. (2007). Resistin- and Obesity-associated metabolic diseases. Hormone and Metabolic Research 39 (10): 710–716. ISSN: 0018-5043. PMID 17952831. DOI: 10.1055/s-2007-985897.
Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale Jr FV, Shelton DL, Hébert CC (August 2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19 (15): 4046–55. PMID 10921885. PMC 306596. DOI: 10.1093/emboj/19.15.4046.
Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, Kumar S, McTernan PG (January 2007). The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes. J. Clin. Endocrinol. Metab. 92 (1): 270–6. PMID 17062773. DOI: 10.1210/jc.2006-1151.
Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (December 2006). Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant. Proc. 38 (10): 3434–6. PMID 17175295. DOI: 10.1016/j.transproceed.2006.10.140.
Nagaev I, Bokarewa M, Tarkowski A, Smith U (2006). Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes. PLOS ONE 1 (1): e31. PMID 17183659. PMC 1762367. DOI: 10.1371/journal.pone.0000031.
Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R (November 2002). Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes. Res. 10 (11): 1095–103. PMID 12429872. DOI: 10.1038/oby.2002.149.
Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (September 2005). Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334 (4): 1092–101. PMID 16039994. DOI: 10.1016/j.bbrc.2005.06.202.
Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (August 2003). Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (6): 736–40. PMID 12874180. DOI: 10.1161/01.CIR.0000084503.91330.49.
Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL (October 2002). Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530 (1–3): 158–62. PMID 12387885. DOI: 10.1016/S0014-5793(02)03450-6.
Wellen KE, Hotamisligil GS (May 2005). Inflammation, stress, and diabetes. J. Clin. Invest. 115 (5): 1111–9. PMID 15864338. PMC 1087185. DOI: 10.1172/JCI25102.

nih.gov (Global: 4^th place; Dutch: 12^th place)

ncbi.nlm.nih.gov

Wang H, Chu WS, Hemphill C, Elbein SC (June 2002). Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87 (6): 2520–4. PMID 12050208. DOI: 10.1210/jcem.87.6.8528.
Lazar MA (October 2007). Resistin- and Obesity-associated metabolic diseases. Horm. Metab. Res. 39 (10): 710–6. PMID 17952831. DOI: 10.1055/s-2007-985897.
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (January 2001). The hormone resistin links obesity to diabetes. Nature 409 (6818): 307–12. PMID 11201732. DOI: 10.1038/35053000.
Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, Considine RV (November 2003). Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88 (11): 5452–5. PMID 14602788. DOI: 10.1210/jc.2002-021808.
Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N (October 2002). Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 (10): 2951–8. PMID 12351432. DOI: 10.2337/diabetes.51.10.2951.
Levy JR, Davenport B, Clore JN, Stevens W (March 2002). Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. Am. J. Physiol. Endocrinol. Metab. 282 (3): E626–33. PMID 11832366. DOI: 10.1152/ajpendo.00346.2001.
McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S (January 2002). Resistin, central obesity, and type 2 diabetes. Lancet 359 (9300): 46–7. PMID 11809189. DOI: 10.1016/S0140-6736(02)07281-1.
Adeghate E (October 2004). An update on the biology and physiology of resistin. Cell. Mol. Life Sci. 61 (19–20): 2485–96. PMID 15526156. DOI: 10.1007/s00018-004-4083-2.
Stumvoll M, Häring H (November 2002). Resistin and adiponectin--of mice and men. Obes. Res. 10 (11): 1197–9. PMID 12429885. DOI: 10.1038/oby.2002.162.
Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C (June 2004). Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12 (6): 962–71. PMID 15229336. DOI: 10.1038/oby.2004.118.
Vidal-Puig, A., O'Rahilly, S. (2001). Resistin: a new link between obesity and insulin resistance?. Clinical Endocrinology 55 (4): 437–438. ISSN: 0300-0664. PMID 11678824. DOI: 10.1046/j.1365-2265.2001.01377.x.
Lazar, M. A. (2007). Resistin- and Obesity-associated metabolic diseases. Hormone and Metabolic Research 39 (10): 710–716. ISSN: 0018-5043. PMID 17952831. DOI: 10.1055/s-2007-985897.
Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale Jr FV, Shelton DL, Hébert CC (August 2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19 (15): 4046–55. PMID 10921885. PMC 306596. DOI: 10.1093/emboj/19.15.4046.
Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, Kumar S, McTernan PG (January 2007). The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes. J. Clin. Endocrinol. Metab. 92 (1): 270–6. PMID 17062773. DOI: 10.1210/jc.2006-1151.
Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (December 2006). Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant. Proc. 38 (10): 3434–6. PMID 17175295. DOI: 10.1016/j.transproceed.2006.10.140.
Nagaev I, Bokarewa M, Tarkowski A, Smith U (2006). Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes. PLOS ONE 1 (1): e31. PMID 17183659. PMC 1762367. DOI: 10.1371/journal.pone.0000031.
Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R (November 2002). Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes. Res. 10 (11): 1095–103. PMID 12429872. DOI: 10.1038/oby.2002.149.
Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (September 2005). Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334 (4): 1092–101. PMID 16039994. DOI: 10.1016/j.bbrc.2005.06.202.
Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (August 2003). Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (6): 736–40. PMID 12874180. DOI: 10.1161/01.CIR.0000084503.91330.49.
Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL (October 2002). Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530 (1–3): 158–62. PMID 12387885. DOI: 10.1016/S0014-5793(02)03450-6.
Wellen KE, Hotamisligil GS (May 2005). Inflammation, stress, and diabetes. J. Clin. Invest. 115 (5): 1111–9. PMID 15864338. PMC 1087185. DOI: 10.1172/JCI25102.

pubmed.ncbi.nlm.nih.gov

Vidal-Puig, A., O'Rahilly, S. (2001). Resistin: a new link between obesity and insulin resistance?. Clinical Endocrinology 55 (4): 437–438. ISSN: 0300-0664. PMID 11678824. DOI: 10.1046/j.1365-2265.2001.01377.x.

worldcat.org (Global: 5^th place; Dutch: 28^th place)

Vidal-Puig, A., O'Rahilly, S. (2001). Resistin: a new link between obesity and insulin resistance?. Clinical Endocrinology 55 (4): 437–438. ISSN: 0300-0664. PMID 11678824. DOI: 10.1046/j.1365-2265.2001.01377.x.
Lazar, M. A. (2007). Resistin- and Obesity-associated metabolic diseases. Hormone and Metabolic Research 39 (10): 710–716. ISSN: 0018-5043. PMID 17952831. DOI: 10.1055/s-2007-985897.

Resistine (Dutch Wikipedia)

archive.org (Global: 6th place; Dutch: 25th place)

doi.org (Global: 2nd place; Dutch: 8th place)

nih.gov (Global: 4th place; Dutch: 12th place)